Monthly Archives: December 2014

William Blair Maintains an Outperform Rating on Franklin Covey Company

In a report released today, Timothy Mchugh from William Blair maintained an Outperform rating on Franklin Covey Company (NYSE: FC). The company’s shares opened today at $19.53. Mchugh said, “• Franklin Covey will release first-quarter results on January 8 after

Cepheid Recieved its Third Outperform in a Row

After Oppenheimer and Citigroup assigned an Outperform rating to Cepheid in the last month, the company received another Outperform, this time from William Blair. Analyst Brian Weinstein reiterated an Outperform rating on Cepheid (NASDAQ: CPHD) today. The company’s shares opened

Valeant Pharma Recieved its Third Buy in a Row

After Guggenheim and TD Securities assigned a Buy rating to Valeant Pharma in the last month, the company received another Buy, this time from Cantor Fitzgerald. Analyst Irina Rivkind reiterated a Buy rating on Valeant Pharma (NYSE: VRX) today and

RAIT Financial Trust Receives a Buy from MLV & Co.

MLV & Co. analyst Rich Eckert reiterated a Buy rating on RAIT Financial Trust (NYSE: RAS) today and set a price target of $9. The company’s shares opened today at $7.81. Eckert commented, “As reported in our last two notes

MLV & Co. Reiterates a Buy Rating on Geo Group

In a report released today, Ryan Meliker from MLV & Co. reiterated a Buy rating on Geo Group (NYSE: GEO), with a price target of $48. The company’s shares opened today at $41.10, close to its 52-week high of $41.23.

2014 Was Eventful for Twitter, But For Better or Worse?

By Sarah Roden Twitter (NYSE: TWTR) made many headlines in 2014 while shares had a tumultuous year. Twitter shares took a tumble in May and fell to its lowest price, approximately $37, since the company went public in the year